1100 rAMUC Two-component pharmaceutical formulation based on recombinant proteins 163rAMUC With postbiotic properties for the treatment of type 2 diabetes and metabolic disorders

IR114208BUndetermined Publication Date: 2026-07-15MS REYHANEH YEGANEH +5
0 Cites 0 Cited by

Patent Information

Application Number
IR140450140003007630
Authority / Receiving Office
IR · IR
Patent Type
Patents
Current Assignee / Owner
Filing Date
2025-11-16
Publication Date
2026-07-15
Estimated Expiration
2045-11-16
Patent Text Reader
Need to check novelty before this filing date? Find Prior Art
No text content released.